Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models
Article in European Journal of Medicinal Chemistry (October 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
Article in Frontiers in Oncology (February 2023)
Emerging targets in gastroesophageal adenocarcinoma: what the future looks like
Article in Therapeutic Advances in Medical Oncology (January 2023)